Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)
- Creators
- Abu-Raya, Bahaa1
- Migliori, Giovanni Battista2
- O'Ryan, Miguel3
- Edwards, Kathryn4
- Torres, Antoni5
- Alffenaar, Jan-Willem6
- Martson, Anne-Grete7
- Centis, Rosella2
- D'Ambrosio, Lia8
- Flanagan, Katie9
- Hung, Ivan10
- Lauretani, Fulvio11
- Leung, Chi Chi12
- Leuridan, Elke13
- Maertens, Kirsten13
- Maggio, Marcello Giuseppe11
- Nadel, Simon14
- Hens, Niel15
- Niesters, Hubert7
- Osterhaus, Albert16
- Pontali, Emanuele17
- Principi, Nicola18
- Rossato Silva, Denise19
- Omer, Saad20
- Spanevello, Antonio2
- Sverzellati, Nicola11
- Tan, Tina Quanbee21, 22
- Torres-Torreti, Juan Pablo3
- Visca, Dina2
- Esposito, Susanna11
- 1. University of British Columbia
- 2. Istituti di Ricovero e Cura a Carattere Scientifico
- 3. University of Chile
- 4. Vanderbilt University
- 5. University of Barcelona
- 6. University of Sydney
- 7. University Medical Center Groningen
- 8. Public Health Consulting Group
- 9. University of Tasmania
- 10. Queen Mary Hospital
- 11. University of Parma
- 12. Hong Kong Tuberculosis, Chest and Heart Diseases Association
- 13. University of Antwerp
- 14. St Mary's Hospital
- 15. Hasselt University
- 16. University of Veterinary Medicine Hannover, Foundation
- 17. Ente Ospedaliero Ospedali Galliera
- 18. University of Milan
- 19. Federal University of Rio Grande do Sul
- 20. Yale University
- 21. Northwestern University
- 22. Lurie Children's Hospital
Abstract
Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.
Other
original_citation: Abu-Raya B, Migliori GB, O'Ryan M, Edwards K, Torres A, Alffenaar JW, Martson AG, Centis R, D'Ambrosio L, Flanagan K, Hung I, Lauretani F, Leung CC, Leuridan E, Maertens K, Maggio MG, Nadel S, Hens N, Niesters H, Osterhaus A, Pontali E, Principi N, Silva DR, Omer S, Spanevello A, Sverzellati N, Tan TN, Torres-Torreti JP, Visca D, Esposito S. Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid). Frontiers in Medicine. 2020;7:20.
Acknowledgements
The article is part of the activities of the Global Tuberculosis Network (GTN), and of the WHO Collaborating Centre for Tuberculosis and Lung Diseases, Tradate, ITA-80, 2017-2020- GBM/RC/LDA)
Files
Name | Size | Download all |
---|---|---|
md5:4fcb40a6743ebabe545cb3dc944e5f8a
|
1.8 MB | Preview Download |
Additional details
- PMID
- 33195319
- Marie Skłodowska-Curie Actions COFUND 2015 529 713660-PRONKJEWAIL-H2020-MSCA-COFUND-2015
- Marie Skłodowska-Curie Actions
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
- Institució Catalana de Recerca i Estudis Avançats
- Created
-
2020-10-30When the item was originally created.